Exploratory classification of clinical phenotypes in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis using cluster analysis
Open Access
- 4 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 11 (1), 1-10
- https://doi.org/10.1038/s41598-021-84627-6
Abstract
A novel patient cluster in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) may be identified in Japan. We performed multiple correspondence and cluster analysis regarding 427 clinically diagnosed AAV patients excluding eosinophilic granulomatosis with polyangiitis. Model 1 included the ANCA phenotype, items of the Birmingham Vasculitis Activity Score, and interstitial lung disease; model 2 included serum creatinine (s-Cr) and C-reactive protein (CRP) levels with model 1 components. In seven clusters determined in model 1, the ANCA-negative (n = 8) and proteinase 3-ANCA-positive (n = 41) groups emerged as two distinct clusters. The other five myeloperoxidase-ANCA-positive clusters were characterized by ear, nose, and throat (ENT) (n = 47); cutaneous (n = 36); renal (n = 256), non-renal (n = 33); and both ENT and cutaneous symptoms (n = 6). Four clusters in model 2 were characterized by myeloperoxidase-ANCA negativity (n = 42), without s-Cr elevation (< 1.3 mg/dL) (n = 157), s-Cr elevation (≥ 1.3 mg/dL) with high CRP (> 10 mg/dL) (n = 71), or s-Cr elevation (≥ 1.3 mg/dL) without high CRP (≤ 10 mg/dL) (n = 157). Overall, renal, and relapse-free survival rates were significantly different across the four clusters in model 2. ENT, cutaneous, and renal symptoms may be useful in characterization of Japanese AAV patients with myeloperoxidase-ANCA. The combination of s-Cr and CRP levels may be predictive of prognosis.Funding Information
- Ministry of Health, Labour and Welfare (nannti-ippann-004, -018)
- Japan Agency for Medical Research and Development (17ek0109104, JP18ek0109360, 17ek0109121)
This publication has 32 references indexed in Scilit:
- Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysisAnnals Of The Rheumatic Diseases, 2012
- Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV studyModern Rheumatology, 2011
- Use of Highly Sensitive C-Reactive Protein for Followup of Wegener’s GranulomatosisThe Journal of Rheumatology, 2010
- A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversityClinical and Experimental Nephrology, 2009
- C‐reactive protein and systemic lupus erythematosusArthritis Care & Research, 2008
- Serum High-Sensitivity C-Reactive Protein Is Not Increased in Patients with IgA NephropathyNephron Clinical Practice, 2007
- EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitisAnnals Of The Rheumatic Diseases, 2007
- Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studiesAnnals Of The Rheumatic Diseases, 2006
- Stable incidence of primary systemic vasculitides over five years: Results from the German vasculitis registerArthritis Care & Research, 2005
- Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvementKidney International, 2003